2017
DOI: 10.1080/00480169.2017.1291376
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine

Abstract: The vaccines containing killed type 1c and type 1a BVD viruses significantly reduced fetal infection following challenge with a New Zealand type 1a BVD virus. Prevention of fetal infection by vaccination may not be 100%, and the risk of persistently infected calves being born to some vaccinated cattle should be acknowledged and managed as part of a BVD control programme.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…The primary role of any pestivirus vaccine is to prevent transplacental infection and thus reduce the rate of PI development 27 . Mechanisms of preventing transplacental infection are complex, with contributing factors including the presence of viraemia outside white blood cells (required for transplacental infection) and the presence of pre‐existing circulating antibody 28 . For this reason, determining the titre of circulating antibody required for foetal protection is non‐definitive 27,28 and so the preferred study design is a challenge study whereby offspring are assessed for pestivirus antigen and antibody 11,20 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The primary role of any pestivirus vaccine is to prevent transplacental infection and thus reduce the rate of PI development 27 . Mechanisms of preventing transplacental infection are complex, with contributing factors including the presence of viraemia outside white blood cells (required for transplacental infection) and the presence of pre‐existing circulating antibody 28 . For this reason, determining the titre of circulating antibody required for foetal protection is non‐definitive 27,28 and so the preferred study design is a challenge study whereby offspring are assessed for pestivirus antigen and antibody 11,20 .…”
Section: Discussionmentioning
confidence: 99%
“…Mechanisms of preventing transplacental infection are complex, with contributing factors including the presence of viraemia outside white blood cells (required for transplacental infection) and the presence of pre‐existing circulating antibody 28 . For this reason, determining the titre of circulating antibody required for foetal protection is non‐definitive 27,28 and so the preferred study design is a challenge study whereby offspring are assessed for pestivirus antigen and antibody 11,20 . This current study did not include a BDV challenge aspect to definitively assess the prevention of PI development and instead a protective titre of >256 was selected, based on a BVDV study conducted by Bolin and Ridpath, 29 who found that calves with a VNT titre of 256 or less exhibited systemic viraemia and fever.…”
Section: Discussionmentioning
confidence: 99%
“…However New Zealand only has BVDV-1, with BVDV-1a and -1c reported. 24,32,33 It is not clear whether seroconversion to a different type 1 virus can occur when an animal is PI with the other.…”
Section: Discussionmentioning
confidence: 99%
“…In New Zealand, the risk that a PI animal would be antibody-positive after maternal immunity has waned appears low, given that only BVDV-1 is present and only BVDV-1a and -1c killed vaccines are available. 24…”
Section: Introductionmentioning
confidence: 99%